{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/delirium/","result":{"data":{"firstChapter":{"id":"0455d257-6ef6-5e50-9dc0-21780666b8e7","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 2a0cf10e-2a73-446b-a560-26daa2204523 --><h1>Delirium: Summary</h1><!-- end field 2a0cf10e-2a73-446b-a560-26daa2204523 -->","htmlStringContent":"<!-- begin item 392513b6-d283-40bc-9c81-6c8f7295f326 --><!-- begin field 2d92d328-deba-4f60-be27-33d660d71663 --><ul><li>Delirium (sometimes called 'acute confusional state') is an acute, fluctuating syndrome of inattention, impaired level of consciousness, and disturbed cognition.</li><li>Delirium can be classified into subtypes based on symptoms:<ul><li>Hyperactive delirium can present with inappropriate behaviour, hallucinations, or agitation.</li><li>Hypoactive delirium can present with lethargy and reduced concentration and appetite.</li><li>Mixed delirium presents with signs and symptoms of both hyperactive and hypoactive subtypes.</li></ul></li><li><div>The prevalence of delirium in primary care is thought to be between 1–2%.</div></li><li><div>Delirium typically occurs in people with a predisposing factor (such as advanced age or multiple co-morbidities) when new precipitating factors (such as some medications or infection) are added.</div></li><li>A diagnosis of delirium can be made if criteria from an assessment tool such as the short Confusion Assessment Method (short-CAM) or the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) are met.</li><li>Most people with delirium require admission to hospital for urgent assessment and multidisciplinary management.</li><li>Management in primary care may be appropriate if all of the following apply:<ul><li>The benefits of management in primary care outweigh the benefits of hospital admission, or the person is clinically well enough to stay at home.</li><li>The symptoms of delirium are not harmful to the person or others, and can be managed safely in primary care.</li><li>The cause of delirium is known and treatable.</li><li>Constant supervision and care is available.</li><li>Close clinical follow-up can be arranged.</li></ul></li><li>Management of delirium in primary care involves:<ul><li>Correcting any precipitating factors (for example infection or constipation).</li><li>Optimizing treatment of comorbidities such as heart failure.</li><li>Giving advice to carers and families on:<ul><li>Reorientation strategies.</li><li>Mobilizing safely.</li><li>Normalizing the person's sleep-wake cycle.</li></ul></li><li>Use of verbal and non-verbal de-escalation techniques to deal with challenging behaviour (such as aggression, agitation, or shouting).<ul><li>Pharmacological treatment such as antipsychotics or benzodiazepines should be avoided, if possible.</li></ul></li></ul><ul><li>Giving verbal and written information on delirium to the person and their carer.</li><li>Reviewing the person's response to treatment within 24 hours and regularly thereafter until symptoms have resolved, and adjusting treatment if appropriate.</li><li>Arranging admission or seeking advice from an elderly care physician or psychiatrist (as appropriate) if the person fails to improve or deteriorates.</li></ul></li><li>If admission is not appropriate, advice should be sought from an elderly care physician or psychiatrist when: <ul><li>There is doubt about the diagnosis. </li><li>The person has severe delirium. </li><li>Detention under the Mental Health Act (1983, amended 2007) is being considered. </li><li>Further investigations not available in primary care are needed. </li><li>The person does not respond to initial treatment in primary care.</li></ul></li></ul><!-- end field 2d92d328-deba-4f60-be27-33d660d71663 --><!-- end item 392513b6-d283-40bc-9c81-6c8f7295f326 -->","topic":{"id":"6b89f111-d1d1-510e-8846-71e15c389f06","topicId":"64430de8-33e7-409d-b433-725a712a6f41","topicName":"Delirium","slug":"delirium","aliases":[],"chapters":[{"id":"0455d257-6ef6-5e50-9dc0-21780666b8e7","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"a71db69b-5a97-544a-a806-ec82704f3907","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"58e84228-4844-5721-859b-91d58faa7eb6","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"999affe9-788e-52a9-83c8-ad933103eeb5","slug":"changes","fullItemName":"Changes"},{"id":"29c67640-566b-5fa4-8966-5b08ca667756","slug":"update","fullItemName":"Update"}]},{"id":"6dddaa0e-c24c-5f4e-8044-6a3229f859df","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"7e8bf385-fd9a-544a-bc9d-375555c17ab0","slug":"goals","fullItemName":"Goals"},{"id":"8f18311c-4fad-5969-8a94-addcca05fb64","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b45b0c3d-03c0-5300-b0c4-62ccd106e229","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7b7d4906-4705-52ba-a39f-ecfb7c5d1e98","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"331ceb18-88fc-530e-aa48-bae28dde9901","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"558ba6d3-06ab-5370-b6b7-09548f2c3c8e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"b6e24e45-958a-5052-800a-ef5c6f140719","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"2b925b35-d493-5d01-bb58-9f18c37e1357","slug":"definition","fullItemName":"Definition"},{"id":"27bd26a5-66e1-5d51-a992-7e06e6a3cdfa","slug":"predisposing-factors","fullItemName":"Predisposing factors"},{"id":"c3582ffa-e505-5580-a3fa-f6a04f0938cc","slug":"precipitating-factors","fullItemName":"Precipitating factors"},{"id":"44402d85-ef9c-562b-ad2c-e99c0d8c60a7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"799dcaa5-4683-5bf0-a9d7-dfc860ab7c81","slug":"complications","fullItemName":"Complications"},{"id":"ca4b25bd-2486-55a7-92c0-c39322caa272","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"993580f3-4201-5dd5-8a6d-f64de509d328","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"3f7d0746-b45f-5f52-8e49-7effac5e3547","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"f84af6b7-85fc-56aa-9554-29d1231a7fd1","slug":"assessment","fullItemName":"Assessment"},{"id":"cc3618cd-d41e-5719-939a-78ed0be305e4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9d04a09f-9612-570d-aeb7-c0121bda09c4","slug":"management","fullItemName":"Management","subChapters":[{"id":"81f2aa66-ed46-54f0-80b5-4dfca4afb344","slug":"management","fullItemName":"Scenario: Management"},{"id":"58bb812f-7b3c-57be-aab1-8ae228aff1d1","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"769a3265-9e21-5508-b937-bf6aa4a8f378","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"fa09afb1-cc68-5f68-afbe-7486c91a5ed4","slug":"haloperidol","fullItemName":"Haloperidol"},{"id":"4faac93d-8b62-5294-933f-214a1155f283","slug":"lorazepam","fullItemName":"Lorazepam"},{"id":"c02516c6-89cb-5dc3-99db-17f261f5f80e","slug":"levomepromazine","fullItemName":"Levomepromazine"}]},{"id":"cd438911-3d3a-51dd-8455-3e41c260dd60","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"cec2028c-5183-50fb-9bb7-f20aea64a152","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"a5323429-af72-5d8b-a251-0715c1a15bba","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"26c6273a-60c7-5b9a-b49f-9f9fbb623941","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b70aed75-14ce-57f4-b2b0-474fa4480d56","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c5faba8c-4118-59d9-af20-8c8d52a89eb2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"71e02a81-885f-515f-8852-109bc9b5580f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"51d66a08-1fc6-5593-8764-c9d4e547d827","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"6b89f111-d1d1-510e-8846-71e15c389f06","topicId":"64430de8-33e7-409d-b433-725a712a6f41","topicName":"Delirium","slug":"delirium","aliases":[],"topicSummary":"Delirium (sometimes called 'acute confusional state') is an acute, fluctuating syndrome of inattention, impaired level of consciousness","lastRevised":"Last revised in April 2020","nextPlannedReviewBy":"2021-11-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2021-11","nextPlannedReviewByDisplay":"November 2021","specialities":[{"id":"460cf76a-c057-55d8-a7ab-50fe9463f7da","name":"Mental health","slug":"mental-health"}],"chapters":[{"id":"0455d257-6ef6-5e50-9dc0-21780666b8e7","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"a71db69b-5a97-544a-a806-ec82704f3907","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"58e84228-4844-5721-859b-91d58faa7eb6","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"999affe9-788e-52a9-83c8-ad933103eeb5","slug":"changes","fullItemName":"Changes"},{"id":"29c67640-566b-5fa4-8966-5b08ca667756","slug":"update","fullItemName":"Update"}]},{"id":"6dddaa0e-c24c-5f4e-8044-6a3229f859df","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"7e8bf385-fd9a-544a-bc9d-375555c17ab0","slug":"goals","fullItemName":"Goals"},{"id":"8f18311c-4fad-5969-8a94-addcca05fb64","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b45b0c3d-03c0-5300-b0c4-62ccd106e229","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7b7d4906-4705-52ba-a39f-ecfb7c5d1e98","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"331ceb18-88fc-530e-aa48-bae28dde9901","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"558ba6d3-06ab-5370-b6b7-09548f2c3c8e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"b6e24e45-958a-5052-800a-ef5c6f140719","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"2b925b35-d493-5d01-bb58-9f18c37e1357","slug":"definition","fullItemName":"Definition"},{"id":"27bd26a5-66e1-5d51-a992-7e06e6a3cdfa","slug":"predisposing-factors","fullItemName":"Predisposing factors"},{"id":"c3582ffa-e505-5580-a3fa-f6a04f0938cc","slug":"precipitating-factors","fullItemName":"Precipitating factors"},{"id":"44402d85-ef9c-562b-ad2c-e99c0d8c60a7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"799dcaa5-4683-5bf0-a9d7-dfc860ab7c81","slug":"complications","fullItemName":"Complications"},{"id":"ca4b25bd-2486-55a7-92c0-c39322caa272","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"993580f3-4201-5dd5-8a6d-f64de509d328","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"3f7d0746-b45f-5f52-8e49-7effac5e3547","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"f84af6b7-85fc-56aa-9554-29d1231a7fd1","slug":"assessment","fullItemName":"Assessment"},{"id":"cc3618cd-d41e-5719-939a-78ed0be305e4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9d04a09f-9612-570d-aeb7-c0121bda09c4","slug":"management","fullItemName":"Management","subChapters":[{"id":"81f2aa66-ed46-54f0-80b5-4dfca4afb344","slug":"management","fullItemName":"Scenario: Management"},{"id":"58bb812f-7b3c-57be-aab1-8ae228aff1d1","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"769a3265-9e21-5508-b937-bf6aa4a8f378","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"fa09afb1-cc68-5f68-afbe-7486c91a5ed4","slug":"haloperidol","fullItemName":"Haloperidol"},{"id":"4faac93d-8b62-5294-933f-214a1155f283","slug":"lorazepam","fullItemName":"Lorazepam"},{"id":"c02516c6-89cb-5dc3-99db-17f261f5f80e","slug":"levomepromazine","fullItemName":"Levomepromazine"}]},{"id":"cd438911-3d3a-51dd-8455-3e41c260dd60","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"cec2028c-5183-50fb-9bb7-f20aea64a152","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"a5323429-af72-5d8b-a251-0715c1a15bba","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"26c6273a-60c7-5b9a-b49f-9f9fbb623941","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b70aed75-14ce-57f4-b2b0-474fa4480d56","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c5faba8c-4118-59d9-af20-8c8d52a89eb2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"71e02a81-885f-515f-8852-109bc9b5580f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"51d66a08-1fc6-5593-8764-c9d4e547d827","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"6b89f111-d1d1-510e-8846-71e15c389f06"}},"staticQueryHashes":["3666801979"]}